ATE232869T1 - Tricyclische delta3-piperidine als alpha2- antagonisten - Google Patents

Tricyclische delta3-piperidine als alpha2- antagonisten

Info

Publication number
ATE232869T1
ATE232869T1 AT99950627T AT99950627T ATE232869T1 AT E232869 T1 ATE232869 T1 AT E232869T1 AT 99950627 T AT99950627 T AT 99950627T AT 99950627 T AT99950627 T AT 99950627T AT E232869 T1 ATE232869 T1 AT E232869T1
Authority
AT
Austria
Prior art keywords
piperidines
alpha2 antagonists
delta3
tricyclic
tricyclic delta3
Prior art date
Application number
AT99950627T
Other languages
English (en)
Inventor
Ludo Edmond J Kennis
Den Keybus F M A Van
Josephus C Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE232869T1 publication Critical patent/ATE232869T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
AT99950627T 1998-10-06 1999-10-01 Tricyclische delta3-piperidine als alpha2- antagonisten ATE232869T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203370 1998-10-06
PCT/EP1999/007419 WO2000020421A2 (en) 1998-10-06 1999-10-01 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS

Publications (1)

Publication Number Publication Date
ATE232869T1 true ATE232869T1 (de) 2003-03-15

Family

ID=8234191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99950627T ATE232869T1 (de) 1998-10-06 1999-10-01 Tricyclische delta3-piperidine als alpha2- antagonisten

Country Status (30)

Country Link
US (1) US6495555B1 (de)
EP (1) EP1119571B1 (de)
JP (1) JP4590101B2 (de)
KR (1) KR20010071843A (de)
CN (1) CN1131230C (de)
AR (1) AR024216A1 (de)
AT (1) ATE232869T1 (de)
AU (1) AU760502B2 (de)
BG (1) BG64872B1 (de)
BR (1) BR9913507A (de)
CA (1) CA2345622C (de)
CZ (1) CZ20011104A3 (de)
DE (1) DE69905478T2 (de)
DK (1) DK1119571T3 (de)
EE (1) EE04770B1 (de)
ES (1) ES2193751T3 (de)
HU (1) HUP0104002A3 (de)
ID (1) ID28032A (de)
IL (1) IL142443A0 (de)
NO (1) NO20011270L (de)
NZ (1) NZ510115A (de)
PL (1) PL347894A1 (de)
PT (1) PT1119571E (de)
RU (1) RU2230744C2 (de)
SI (1) SI1119571T1 (de)
SK (1) SK285585B6 (de)
TR (1) TR200100952T2 (de)
TW (1) TWI248441B (de)
UA (1) UA69420C2 (de)
WO (1) WO2000020421A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2346082C (en) * 1998-10-06 2010-02-16 Janssen Pharmaceutica N.V. Tricyclic .delta.3-piperidines as pharmaceuticals
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
AU2005233456A1 (en) 2004-04-12 2005-10-27 Taisho Pharmaceutical Co., Ltd. Cyclic amine compound
EP1775283A4 (de) * 2004-07-14 2008-12-10 Japan Tobacco Inc 3-aminobenzamid-verbindung und hemmer der aktivität des vanilloid-rezeptors 1 (vr1)
KR101042490B1 (ko) * 2004-07-15 2011-06-16 니뽄 다바코 산교 가부시키가이샤 축합 벤즈아미드 화합물 및 바닐로이드 수용체 1형(vr1)활성 저해제
US7906508B2 (en) * 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
CN102459251B (zh) 2009-05-14 2015-05-20 詹森药业有限公司 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物
WO2015091420A1 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
SG11201604949XA (en) 2013-12-19 2016-07-28 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines
AP2016009276A0 (en) * 2013-12-19 2016-06-30 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines and their use as alpha-2c adrenoreceptor antagonists
CN114276359B (zh) * 2022-01-05 2023-05-05 浙江大学 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU926914A1 (ru) * 1980-05-26 1992-04-23 Научно-исследовательский институт фармакологии АМН СССР Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
CA2272330A1 (en) * 1996-12-06 1998-06-11 Irene Drizin Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
US6498251B1 (en) * 1997-12-25 2002-12-24 Meiji Seika Kaisha, Ltd. Tetrahydrobenzindole derivatives
CA2346082C (en) * 1998-10-06 2010-02-16 Janssen Pharmaceutica N.V. Tricyclic .delta.3-piperidines as pharmaceuticals

Also Published As

Publication number Publication date
TR200100952T2 (tr) 2001-10-22
UA69420C2 (uk) 2004-09-15
SK4322001A3 (en) 2002-01-07
BR9913507A (pt) 2001-06-05
PT1119571E (pt) 2003-06-30
BG64872B1 (bg) 2006-07-31
KR20010071843A (ko) 2001-07-31
HUP0104002A2 (hu) 2002-03-28
HUP0104002A3 (en) 2003-12-29
CN1131230C (zh) 2003-12-17
EP1119571B1 (de) 2003-02-19
DE69905478T2 (de) 2004-03-18
NO20011270D0 (no) 2001-03-13
HK1038010A1 (en) 2002-03-01
NO20011270L (no) 2001-03-13
ES2193751T3 (es) 2003-11-01
AU760502B2 (en) 2003-05-15
SI1119571T1 (en) 2003-08-31
DE69905478D1 (de) 2003-03-27
WO2000020421A2 (en) 2000-04-13
TWI248441B (en) 2006-02-01
IL142443A0 (en) 2002-03-10
RU2230744C2 (ru) 2004-06-20
AR024216A1 (es) 2002-09-25
US6495555B1 (en) 2002-12-17
AU6334199A (en) 2000-04-26
EE200100209A (et) 2002-06-17
SK285585B6 (sk) 2007-04-05
CA2345622C (en) 2007-12-04
PL347894A1 (en) 2002-04-22
CZ20011104A3 (cs) 2001-12-12
NZ510115A (en) 2002-11-26
CA2345622A1 (en) 2000-04-13
CN1332744A (zh) 2002-01-23
EP1119571A2 (de) 2001-08-01
JP4590101B2 (ja) 2010-12-01
WO2000020421A3 (en) 2000-08-03
EE04770B1 (et) 2007-02-15
BG105332A (en) 2001-11-30
DK1119571T3 (da) 2003-05-26
JP2002526545A (ja) 2002-08-20
ID28032A (id) 2001-05-03

Similar Documents

Publication Publication Date Title
IS6267A (is) Ný spíróefnasambönd
NO20003706L (no) Ny tricyklisk forbindelse
EP0986385A4 (de) Antagonisten des gonadorelins
DE69719354D1 (de) Muscarin-antagonisten
ID30132A (id) Turunan-turunan pirazol trisiklik
DE69911259D1 (de) Tricyclische benzodiazepine als vasopressin antagonisten
NO991821D0 (no) Substituerte tricykliske forbindelser
PT1131291E (pt) Antagonistas iii do receptor 4-aroil-piperidin-ccr-3
DK0804440T3 (da) Tricykliske benzazapin-vasopressionantagonister
EE200000171A (et) Uued NPY antagonistid
DK0839806T3 (da) Substituerede tricykliske forbindelser
DE69714265D1 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
DE69718786D1 (de) Benzoxazinone als dopamine -d4- rezeptor-antagonisten
DE69626220D1 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
PT1144411E (pt) Compostos espiro anti-histaminicos
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
ATE232869T1 (de) Tricyclische delta3-piperidine als alpha2- antagonisten
NO991823D0 (no) Substituerte tricykliske forbindelser
ATE240954T1 (de) Oxazolidinone als 5-ht2a-antagonisten
NO20022847D0 (no) Nye substituerte tricykliske forbindelser
DE69735811D1 (de) Piperazinoderivate als neurokinin-antagonisten
DE60009931D1 (de) Muscarin-antagonisten
ATE280161T1 (de) Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1119571

Country of ref document: EP

REN Ceased due to non-payment of the annual fee